NCT06829043View on ClinicalTrials.gov

18F-FDG PET/TC in TIR3A E TIR3B

Enrolling by invitationOBSERVATIONAL
Enrollment

216

Participants

Timeline

Start Date

March 22, 2022

Primary Completion Date

December 12, 2024

Study Completion Date

February 1, 2027

Conditions
PET / CTFDG PET/CTCytologyThyroid Nodules
Interventions
OTHER

clinical practice drug treatment

The study is observational, non-interventional and involves the review of the investigation18F-FDGPET/TC (performed according to the EANM guidelines) by two experts from the Nuclear Medicine Department.

Trial Locations (1)

40138

Nuclear medicine, IRCCS, Azienda Ospedalierio-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER